We have previously described the development of virus-specific helper T cell hybridomas which recognize structural determinants shared by type 1 and type 3 reoviruses that have been exposed to UV radiation. We have found that T-cell hybridomas become persistently infected with live type 3 reovirus used for the immunization. Persistently infected T-hybridoma cells were found to spontaneously produce interleukin 2 (IL-2). To analyze the mechanism of induction of IL-2 secretion of persistently infected T-cell hybridomas, we exposed T-cell hybridomas specific for UV-treated virus to replicating type 3 reovirus. The T-cell hybridomas became infected but did not produce IL-2 unless simultaneously exposed to syngeneic I-A+ antigen-presenting cells. In this situation, the persistently infected T-cell hybridomas produced IL-2 without being reexposed to virus. This process was not a consequence of nonspecific IL-2 gene activation, which occurs in cells persistently infected with reovirus, because reovirus infection did not activate IL-2 secretion in T-cell hybridomas with other antigenic specificities. Reovirus exposure also resulted in persistent infection of certain antigen-presenting B-cell tumor lines. The persistently infected B-cell tumor lines could stimulate reovirus-specific helper T cells but not T-cell hybridomas of other specificities. The data support the thesis that persistent infection of reovirus-specific T cells creates a mechanism in which the virus released from these cells is processed and then reexpressed by I-A + antigen-presenting cells. The IA antigen and reovirus structures on the antigen-presenting cells then restimulate the T cells through their specific receptors, resulting in IL-2 synthesis and release. These observations may be relevant to mechanisms of autoimmunity induced by virus.
Immunologic interactions between host cells and viruses have been investigated extensively and have provided insights into the role of T-cell immunity in host defense against viral infection (6, 25) . In addition, studies with viruses helped to clarify the major histocompatibility complexinduced restriction of T-cell recognition of foreign antigens on target cells (48) .
Studies with the mammalian reoviruses have identified important genetic determinants involved in viral virulence (15, 27, 36) . The mammalian reoviruses are segmented, double-stranded RNA viruses which have three outer capsid proteins (ulC [1, 4] ) that play distinct roles in viral virulence (36) . One of these proteins, the sigma 1 protein (hemagglutinin) encoded in the Si RNA segment of the virus, has been shown to be the cell attachment protein (22, 44) . One antigenic domain of the reoviral hemagglutinin identified by the neutralizing monoclonal antibody (9BG5) (7, 44) , determines several biological interactions between reovirus and its cell surface receptor. Attachment and entry of virus can be blocked partially by the monoclonal anti-receptor antibody, 87.92.6 (21) , which has been raised against the antigen-binding site of the 9BG5 neutralizing monoclonal antibody (27, 28) . The neutralization domain also provides a target for a significant proportion of the cytotoxic T-cell responses to reovirus (16, 28) . The anti-receptor antibody can block a significant proportion of the reovirus-specific cytolytic activity (14, 28, 29) . * Corresponding author.
Reovirus can infect some transformed lines without lysing the cells, resulting in persistent infection (2) . L cells that are persistently infected with reoviruses show identifiable morphological changes (1) . Such cells have altered cytoskeletons and contain a large number of lysosomelike structures in the cytoplasm. Reoviruses which persistently infect L cells show gradual changes in the hemagglutinin gene. The hemagglutinin protein is readily identifiable on the cell surface of the persistently infected cells. These persistently infected cells are also suitable targets for reovirus-specific cytolytic cells (36) .
In a previous study (V. H. Hinshaw, N. Matsuzaki, B. N. Fields, D. Furlong, and M. I. Greene, submitted for publication), we reported the development and the immunological characteristics of several reovirus-specific helper T-cell hybridomas induced with UV irradiation-treated type 3 reovirus. The T-cell hybridomas recognized epitopes of type 3 reovirus that became exposed after UV irradiation and which were shared with UV-irradiated type 1 reovirus. UV irradiation of reovirus was found to affect the outer capsid, leading to the complete loss of the sigma 1 protein. The reactivity to non-sigma 1 shared epitopes after immunization with UV-treated virus distinguishes the response from specific immune responses evoked by live virus.
In the present study, we immunized and fused live reovirus-primed T cells with BW5147 thymoma cells to obtain T-cell hybridomas specific for reovirus type 3. After exposure to live virus, the hybridoma cells spontaneously produced IL-2 as a consequence of developing persistent infection. To explore the mechanism of autostimulation of T-cell hybridomas, we intentionally infected the specific T-cell hybridomas with reovirus. We observed that type 3 reovirus can persistently infect T-cell hybridomas and also certain antigen-presenting cell lines. We also determined that reovirus type 3 is released from the persistently infected T cell hybridoma and is bound and then processed by I-A' antigen-presenting cells and thereafter presented to the persistently infected reovirus type 3-specific T-cell hybridomas. Recognition of the I-A-reovirus antigenic complex antigen-presenting cell results in IL-2 production and secretion. The relevance of these observations to autoimmunity after virus infections is discussed.
MATERIALS AND METHODS Animnals. Female BALB/c mice were purchased from the Jackson Laboratories, Bar Harbor, Maine, and were maintained on standard lab chow and water ad libitum.
Virus. The origins of reovirus serotype 1 (Lang) and serotype 3 (Dearing) have been described previously (32) . All viruses used in this study were purified from infected L-cell extract by procedures described previously (11, 39) .
Cells. The development of T-cell hybridomas specific for UV-treated type 3 reovirus has been described elsewhere (Hinshaw et al., submitted). T-cell hybridomas induced by live reovirus immunization were established by the general procedure described by Kappler et al. (20) . BALB/c mice were immunized with intraperitoneal injection of 107 PFU of live reovirus type 3. Spleens were removed 1 week after the immunization and stimulated in vitro with reovirus-infected, irradiated (2,000 rad) syngenic spleen cells. After 4 days, viable cells were isolated on Ficoll-Hypaque gradients and fused with BW 5147 thymoma cells by using polyethylene glycol (molecular weight, 330 to 1,600; American Type Culture Collection, Rockville, Md.). The fused cells were cultured first in hypoxanthine-aminopterin-thymidine medium, next in hypoxanthine-thymidine medium, and then in medium used in the laboratory for T-cell hybridoma propagation (RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, 10% NCTC 109 medium [M.A. Bioproducts], 4 mM L-glutamine, 1% antibiotics-antimycotic mixture [penicillin, 10,000 IU/ml; streptomycin, 10,000 IU/ml; fungizone, 25 ,g/ml; GIBCO specific) and A2.2B2 (hen egg white lysozyme [HEL] specific), were kindly provided by L. H. Glimcher. TA-3, an antigen-presenting B-cell hybridoma, was also a gift of L. H. Glimcher (17, 19) . TA-3 was maintained in RPMI 1640 supplemented with 10% fetal calf serum, 4 mM L-gluthamine, 15 mM HEPES, 1% antibiotics-antymycotic mixture, and 5 x 10-5 M 2-mercaptoethanol.
Antigen. KLH (500 ,ug/ml) and HEL (100 ,ug/ml) were provided by M. Slaoui. Purified type 1 and type 3 reoviruses were used at 107 PFU/ml. Stimulation of IL-2 production. T-cell hybridoma cells (105) and TA-3 cells (104) were placed with the optimum concentration of antigen in 200-,lI cultures. Supernatant fluids from these cultures were harvested at 24 h, and the level of IL-2 was assayed as described previously (17, 19) . IL-2 assay. IL-2 was assayed as described in previous studies (17, 19) . Briefly, the culture supernatants were tested for the presence of IL-2 in the microassay by an IL-2- (46) . Briefly, B-cell hybridomas were suspended at 5 x 106/ml in balanced salt solution containing 0.5% freshly prepared paraformaldehyde. The cells were then incubated for 20 min at room temperature, and fixation was stopped by addition of cold balanced salt solution-10% fetal calf serum. The cells were pelleted by centrifugation and washed three times in balanced salt solution-fetal calf serum before being placed into culture.
Treatment of antigen-presenting B-cell hybridomas with chloroquine. Chloroquine was kindly provided by P. M. Allen, Harvard Medical School. To pulse B-cell hybridomas in the presence of 0.1 mM chloroquine, 5 x 106 cells were incubated in medium containing the drug for 30 min at 37°C.
The cells were pelleted by centrifugation and suspended in medium containing the drug along with the antigen. After incubation for 2 h at 37°C, the cells were washed extensively and then fixed with 0.5% paraformaldehyde (5, 8, 47) . RESULTS Reactivity patterns of T-cell hybridomas after live type 3 reovirus immunization. In a previous study (Hinshaw et al., submitted), we showed that T-cell hybridomas induced with UV-treated reovirus type 3 were specific for determinants other than those expressed on the hemagglutinin. We demonstrated that UV treatment of type 3 reovirus destroys the sigma 1 protein (viral hemagglutinin) which determines the cellular and neural tropism of the reovirus serotype 3 (40, 44) .
To analyze T helper cells specific for sigma 1, we immunized BALB/c mice with live type 3 reovirus. T-cell hybridomas generated after reovirus type 3 immunization demonstrated the reactivity pattern shown in Table 1 . During screening, T-cell hybridomas which showed positive responses to type 3 reovirus could be categorized into two groups. T-cell hybridomas in group 1, exemplified by the U37T cells (a T-cell hybridoma line) were stimulated with the reovirus serotypes (107 PFU/ml) indicated. The culture supernatants were then assayed for IL-2. The results were expressed as the geometric mean. The standard deviation was within 10% of the mean.
I TA-3 cells (antigen-presenting B-cell hybridomas) were used after irradiation (8,000 rad).
' Culture media containing the virus were transferred to the IL-2-dependent T-cell line (HT-2), and proliferation of this cell line was measured.
U113 hybrid, seemed to respond to common determinants between live reovirus type 1 and type 3. T-cell hybridomas in group 2, such as U54 in contrast, produced IL-2 regardless of the added antigen. All T-cell hybridomas in group 1, upon restimulation with reovirus 3, gradually changed to reveal the same reactivity pattern of T-cell hybridomas as in group 2. These findings suggest that the hybridomas were induced to spontaneously produce IL-2 or developed responsiveness to some other antigens in the system.
We analyzed all of the hybridomas for infectious virus by using plaque assays of hybridoma cell lysates on L cells. All IL-2-producing hybridomas were observed to become persistently infected after restimulation with live reovirus 3. Viral proteins were also detected on the membranes of the hybridomas, as determined by flow microfluorimetry (unpublished results). T-cell hybridomas such as U113 were not initially infected with reovirus 3 but became persistently infected after restimulation with live reovirus 3.
To determine the cellular requirements for IL-2 production, we evaluated the response of a persistently infected hybridoma to UV-treated and live virus in the presence and absence of irradiated TA-3 cells which we used as a source of antigen-presenting cells. Only the combination of persistently infected T-cell hybridoma cells and TA-3 cells resulted in the production of IL-2. (Table 2 ). We concluded that reovirus 3-specific T-cell hybridomas persistently infected with type 3 reovirus become activated upon coculture of TA-3 cells without the need for further exogenous antigen.
Establishment of persistently infected T-cell hybridomas and their specificity in activation by virus infection. To determine the reason why persistently infected T-cell hybridomas produce IL-2 after coculture of antigen-presenting cells without further reovirus stimulation, we deliberately infected reovirus-specific T-cell hybridomas with live type 3 reovirus and examined their ability to produce IL-2. However, T-cell hybridomas which were uninfected were activated only by specific viral antigen (Fig. 1) . Uninfected hybridomas responded to live type 3 reovirus but not to live type 1 reovirus (Fig. 1, groups 1 through 3) . These hybridomas produced IL-2 regardless of exogenous virus stimulation when cultured with the TA-3 antigen-presenting B-cell hybridoma (Fig. 1, groups T-cell hybrids. Furthermore, the antigen-presenting cells must be IA syngeneic with the T-cell hybridomas to induce IL-2 secretion. Collectively, these studies suggest that persistently infected reovirus-specific T-cell hybrids secrete IL-2 only when mixed with IA' syngeneic antigenpresenting cells.
Only live type 3 reovirus could infect reovirus type 3-specific T-cell hybridomas to produce IL-2 (Fig. 2) reovirus, failed to induce IL-2 secretion. We also examined the persistently infected T-cell hybridomas (12T.103 and 99T.140) histologically but could not find any gross morphological alterations when we compared them with uninfected T-cell hybridomas (data not shown).
Moreover, to exclude the possibility that cells persistently infected with type 3 reovirus contain nonspecifically activated IL-2 genes, T-cell hybridomas with other antigenic specificities were deliberately infected with type 3 reovirus and thereafter examined for their ability to produce IL-2. Two T-cell hybridomas specific for KLH and HEL (2A1 and A2.2B2, respectively) responded to their specific antigens and produced IL-2 (Table 3) . These T-cell hybrids, despite becoming infected with reovirus 3, required their nominal antigen and TA-3 cells to be induced to secrete IL-2. Therefore, the production of IL-2 by these hybridomas was neither augmented nor inhibited by virus infection. This experiment demonstrates that persistent infection with the mammalian reovirus does not alter T-cell hybridoma specificity and does not activate IL-2 genes nonspecifically.
Furthermore, only T-cell hybridomas with reovirus 3 hemagglutinin specificity upon becoming persistently infected with reovirus 3 are able to secrete IL-2 when exposed to syngeneic antigen-presenting cells without further exogenous antigen. Collectively, these data suggest that persistently infected T cells specific for reovirus 3 only require IA+ antigen-presenting cells to be induced to secrete IL-2.
The role of antigen-presenting cells in persistent infection by reovirus. We have previously shown that immunological interactions between reovirus-specific T-cell hybrids and antigen-presenting cells are IA restricted (Hinshaw et al., submitted). We infected TA-3 cells with live type 1 or type 3 reovirus to examine their influence on noninfected reovirusspecific T-cell hybrids. Only type 3 reovirus-infected or -pulsed TA-3 cells could activate reovirus 3-specific T-cell hybridomas, while type 1-infected or -pulsed TA-3 cells failed to do so (Table 4 ). This activation was IAd restricted (Table 5) .
To evaluate the uptake, processing, and presentation of reovirus in persistently infected antigen-presenting cells, TA-3 cells were treated as described by Ziegler et al. (5, 8) . Membranes of antigen-presenting cells were fixed with 0.5% paraformaldehyde to block the uptake and subsequent catabolism of virus. We also used 0.1 mM chloroquine to disrupt normal lysosomal function. Chloroquine is thought to increase lysosomal pH, leading to a susbequent depression of activity of acid hydrolases within endosomes. To inhibit reovirus receptor cycling, B-cell hybridomas were fixed with 0.5% paraformaldehyde after chloroquine treatment (5). Persistently infected TA-3 cells successfully activated uninfected T-cell hybridomas after membrane fixation by paraformaldehyde, but not after the blocking of both the intracellular processing and subsequent presentation steps by the combination of chloroquine and paraformaldehyde (Fig. 3) .
We also examined whether viral presentation by uninfected TA-3 cells could be modulated by these procedures. Uninfected antigen TA-3 cells failed to present the virus to activate reovirus-specific helper T cells after being blocked either at the antigen uptake level by paraformaldehyde or at the antigen processing and representation steps by the combination of chloroquine and paraformaldehyde (Fig. 4) . These results indicate that there are dramatic differences in the mechanism of antigen presentation in TA-3 cells that have become persistently infected with mammalian reovirus as compared with that in uninfected TA-3 cells.
DISCUSSION
We have demonstrated that immunization with reovirus type 3 leads to the generation of reovirus 3-specific helper T cells. We have used these cells to create reovirus 3-specific T-cell hybridomas. The reovirus type 3-specific T-cell hybridomas were found to become persistently infected upon exposure to replicating virus. The reoviruses can be directly visualized in the cytoplasm by immunofluorescence microscopy and on the membrane by fluorescence-activated cell sorter analysis of persistently infected cells (unpublished data); the virus can be recovered, and titers can be determined in conventional plaque assays. However, we observed that persistently infected T-cell hybridomas can be (9, 10, 26) . The receptor is a single polypeptide chain, with a mass of 65 kilodaltons and a pl of 5.9 to 6.1, which binds the hemagglutinin of reovirus type 3. In further studies, the somatic receptor was identified as structurally similar to the mammalian beta-adrenergic receptor which is expressed in high density on lymphocyte and neuronal cell membranes.
We have recently shown that two structurally distinct receptors for reovirus (hemagglutinin) recognition, namely the heterodimeric immune T-cell receptor and the monomeric somatic receptor (28) can be identified by a monoclonal anti-receptor antibody (14, 37, 38) . This finding suggested that there is a configurational relationship between these two receptor systems. The mechanism by which reovirus enters cells such as the TA-3 line might occur by binding to somatic receptors on the cell surface or, alternatively, by an active phagocytic mechanism that permits viral entry without requiring specific binding to receptors. However, it is possible that reovirus might enter the T-cell hybridomas via immune receptors or somatic receptors.
Functional analyses of persistently infected lymphoid cells has been limited (23). Ahmed and Oldstone (4) have found that genetic variants of LCMV inhibit LCMV-specific cytolytic activity responses in an incompletely defined manner during persistent infection. These studies indicate that LCMV variants may demonstrate tropism for certain subsets of cells resulting in their inhibition or inactivation. Our results indicate that the helper T-cell hybrids persistently infected with reovirus type 3, rather than being functionally inhibited, can be induced to secrete IL-2 growth factors when placed in proximity to antigen-presenting cells.
Prior studies in our laboratories and others have shown that reovirus can cause persistent infections in cell culture systems (1) (2) (3) . In persistent infection of mouse L cells by reoviruses, it is clear that virus undergoes extensive mutations and the cells are also affected by viral infection (1, 3) . We have not studied the functional changes seen in such cells, although it is clear that in L cells there may be profound structural changes (1; unpublished data). The differences between these two viral systems (LCMV and reovirus) most likely relate to the distinct biological properties of the viruses.
Human T-cell leukemia-lymphoma virus (type I) (HTLV-1) has been shown to induce a variety of alterations in persistently infected rodent and human T lymphocytes (41, 42) . Yodoi et al. found that HTLV-I infection induces the expression of IL-2 receptor proteins in infected human and rat T-cell lines (41, 45) . An antigen-specific T-cell clone was observed to proliferate and secrete interferon proteins and B-cell helper factors continuously after HTLV-1 infection. T cells which have been completely transformed by HTLV-1 produced no detectable IL-2 in response to the specific antigen, suggesting a loss of some normal function of these cells (31, 42) .
In immunogenic form after the interaction with la molecules present on antigen-presenting cells. The concept of a processing step during H-2-restricted antigen presentation has been previously proposed (46, 47 
